Literature DB >> 27012756

Knee Injury and Osteoarthritis Outcome Score (KOOS): systematic review and meta-analysis of measurement properties.

N J Collins1, C A C Prinsen2, R Christensen3, E M Bartels4, C B Terwee5, E M Roos6.   

Abstract

OBJECTIVE: To conduct a systematic review and meta-analysis to synthesize evidence regarding measurement properties of the Knee injury and Osteoarthritis Outcome Score (KOOS).
DESIGN: A comprehensive literature search identified 37 eligible papers evaluating KOOS measurement properties in participants with knee injuries and/or osteoarthritis (OA). Methodological quality was evaluated using the COSMIN checklist. Where possible, meta-analysis of extracted data was conducted for all studies and stratified by age and knee condition; otherwise narrative synthesis was performed.
RESULTS: KOOS has adequate internal consistency, test-retest reliability and construct validity in young and old adults with knee injuries and/or OA. The ADL subscale has better content validity for older patients and Sport/Rec for younger patients with knee injuries, while the Pain subscale is more relevant for painful knee conditions. The five-factor structure of the original KOOS is unclear. There is some evidence that the KOOS subscales demonstrate sufficient unidimensionality, but this requires confirmation. Although measurement error requires further evaluation, the minimal detectable change for KOOS subscales ranges from 14.3 to 19.6 for younger individuals, and ≥20 for older individuals. Evidence of responsiveness comes from larger effect sizes following surgical (especially total knee replacement) than non-surgical interventions.
CONCLUSIONS: KOOS demonstrates adequate content validity, internal consistency, test-retest reliability, construct validity and responsiveness for age- and condition-relevant subscales. Structural validity, cross-cultural validity and measurement error require further evaluation, as well as construct validity of KOOS Physical function Short form. Suggested order of subscales for different knee conditions can be applied in hierarchical testing of endpoints in clinical trials. SYSTEMATIC REVIEW REGISTRATION: PROSPERO (CRD42011001603).
Copyright © 2016 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  KOOS; Knee injury; Knee osteoarthritis; Measurement properties; Meta-analysis; Patient-reported outcome measures

Mesh:

Year:  2016        PMID: 27012756     DOI: 10.1016/j.joca.2016.03.010

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  126 in total

1.  Validity and Responsiveness of the Knee Injury and Osteoarthritis Outcome Score: A Comparative Study Among Total Knee Replacement Patients.

Authors:  Barbara Gandek; John E Ware
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-05-08       Impact factor: 4.794

2.  Rapid Progression of Knee Pain and Osteoarthritis Biomarkers Greatest for Patients with Combined Obesity and Depression: Data from the Osteoarthritis Initiative.

Authors:  Cale A Jacobs; Ana-Maria Vranceanu; Katherine L Thompson; Christian Lattermann
Journal:  Cartilage       Date:  2018-06-01       Impact factor: 4.634

3.  Evaluation of the Combined Application of Neuromuscular Electrical Stimulation and Volitional Contractions on Thigh Muscle Strength, Knee Pain, and Physical Performance in Women at Risk for Knee Osteoarthritis: A Randomized Controlled Trial.

Authors:  Kaitlin G Rabe; Hiroo Matsuse; Anthony Jackson; Neil A Segal
Journal:  PM R       Date:  2018-05-29       Impact factor: 2.298

4.  Preoperative KOOS and SF-36 Scores Are Associated With the Development of Symptomatic Knee Osteoarthritis at 7 Years After Anterior Cruciate Ligament Reconstruction.

Authors:  J Kristopher Ware; Brett D Owens; Matthew R Akelman; Naga Padmini Karamchedu; Paul D Fadale; Michael J Hulstyn; Robert M Shalvoy; Gary J Badger; Braden C Fleming
Journal:  Am J Sports Med       Date:  2018-02-05       Impact factor: 6.202

5.  Cross-cultural adaptation and validation of the Saudi Arabic version of the Knee Injury and Osteoarthritis Outcome Score (KOOS).

Authors:  Saud A Alfadhel; Vishal Vennu; Ali H Alnahdi; Mohammed T Omar; Saeed H Alasmari; Zahra AlJafri; Saad M Bindawas
Journal:  Rheumatol Int       Date:  2018-06-07       Impact factor: 2.631

6.  Patient-Reported Outcomes One to Five Years After Anterior Cruciate Ligament Reconstruction: The Effect of Combined Injury and Associations With Osteoarthritis Features Defined on Magnetic Resonance Imaging.

Authors:  Brooke E Patterson; Adam G Culvenor; Christian J Barton; Ali Guermazi; Joshua J Stefanik; Kay M Crossley
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-03       Impact factor: 4.794

Review 7.  Effects of technology-supported exercise programs on the knee pain, physical function, and quality of life of individuals with knee osteoarthritis and/or chronic knee pain: A systematic review and meta-analysis of randomized controlled trials.

Authors:  Tianrong Chen; Calvin Kalun Or; Jiayin Chen
Journal:  J Am Med Inform Assoc       Date:  2021-02-15       Impact factor: 4.497

8.  Every second retired elite female football player has MRI evidence of knee osteoarthritis before age 50 years: a cross-sectional study of clinical and MRI outcomes.

Authors:  Annika Prien; Sana Boudabous; Astrid Junge; Evert Verhagen; Bénédicte M A Delattre; Philippe M Tscholl
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-06-17       Impact factor: 4.342

9.  Self-efficacy, pain, and quadriceps capacity at baseline predict changes in mobility performance over 2 years in women with knee osteoarthritis.

Authors:  Nicholas M Brisson; Anthony A Gatti; Paul W Stratford; Monica R Maly
Journal:  Clin Rheumatol       Date:  2017-11-10       Impact factor: 2.980

10.  Composite metric R2  - R (1/T2  - 1/T ) as a potential MR imaging biomarker associated with changes in pain after ACL reconstruction: A six-month follow-up.

Authors:  Colin Russell; Valentina Pedoia; Sharmila Majumdar
Journal:  J Orthop Res       Date:  2016-09-16       Impact factor: 3.494

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.